Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 4/2008

01.07.2008 | How to do it

Duodenum-preserving total pancreatic head resection for cystic neoplasm—a limited but cancer-preventive procedure

verfasst von: Hans G. Beger, Bettina M. Rau, Frank Gansauge, Michael Schwarz, Marko Siech, Bertram Poch

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Cystic neoplastic lesions of the pancreas are found in up to 10% of all pancreatic lesions. A malignant transformation of cystic neoplasia is observed in intraductal papillary mucinous tumor (IPMN) lesions in 60% and in mucinous cystic tumor (MCN) lesions in up to 30%. For cystic neoplasia located monocentrically in the pancreatic head and that do not have an association with an invasive pancreatic cancer, the duodenum-preserving total head resection has been used in recent time as a limited surgical procedure.

Patients

An indication to duodenum-preserving total pancreatic head resection is considered for patients who do not have clinical signs of an advanced cancer in the lesion and who have main-duct IPMN and monocentric MCN lesions. In 104 patients with cystic neoplastic lesions in the Ulm series, 32% finally had a carcinoma in situ or an advanced pancreatic cancer. The application of a duodenum-preserving total pancreatic head resection in patients with asymptomatic cystic lesion is based on the size of the tumor and the tumor relation to the pancreatic ducts. For patients who have preoperatively clinical signs of malignancy, a Kausch–Whipple type of oncologic resection is recommended.

Results

Duodenum-preserving total pancreatic head resection is used in several modifications. The surgical procedure is a limited pancreatic head resection which necessitates segmental resection of the peripapillary duodenum. Hospital mortality is very low; in most published series it is 0%. The long-term outcome is determined by completeness of resection for both—benign and malignant—entities. Careful evaluation of the frozen section results has a pivotal role for intraoperative decision making.

Conclusion

A duodenum-preserving total pancreatic head resection is a limited surgical procedure for patients who suffer a local monocentric, cystic neoplastic lesion in the pancreatic head. Absence of an advanced pancreatic cancer and completeness of extirpation of the benign tumor determine the long-term outcome. In regards to the location of the lesion in the pancreatic head, several modifications have been applied with low hospital morbidity and mortality below 1%.
Literatur
1.
Zurück zum Zitat Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, Pederzoli P (2007) Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate. Pancreas 56:1086–1090 Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, Pederzoli P (2007) Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate. Pancreas 56:1086–1090
2.
Zurück zum Zitat Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32PubMedCrossRef Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32PubMedCrossRef
3.
Zurück zum Zitat Formentini A, Birk D, Siech M, Mattfeldt T, Fortnagel G, Beger HG (2000) Serous cystadenocarcinoma of the pancreas; serous cystadenoma associated with ductal pancreatic adenocarcinoma. HPB 2:41–48 Formentini A, Birk D, Siech M, Mattfeldt T, Fortnagel G, Beger HG (2000) Serous cystadenocarcinoma of the pancreas; serous cystadenoma associated with ductal pancreatic adenocarcinoma. HPB 2:41–48
4.
Zurück zum Zitat Hoon Chi S, Min Kim S, Tak Oh J, Young Park J, Meen SJ, Koo Lee S (2006) Solid pseudopapillary tumor of the pancreas: a multicenter study of 23 pediatric cases. J Pediatr Surg 41:1992–1995CrossRef Hoon Chi S, Min Kim S, Tak Oh J, Young Park J, Meen SJ, Koo Lee S (2006) Solid pseudopapillary tumor of the pancreas: a multicenter study of 23 pediatric cases. J Pediatr Surg 41:1992–1995CrossRef
5.
Zurück zum Zitat Beger HG, Rau BM, Siech M, Schwarz M, Poch B (2008) Duodenum-preserving pancreatic head resection for cystic neoplastic head lesions. J Hepatobiliary Pancreat Surg 15:149–156 Beger HG, Rau BM, Siech M, Schwarz M, Poch B (2008) Duodenum-preserving pancreatic head resection for cystic neoplastic head lesions. J Hepatobiliary Pancreat Surg 15:149–156
6.
Zurück zum Zitat Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Matsuno S, Furukawa T (1999) Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 134:1131–1136PubMedCrossRef Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Matsuno S, Furukawa T (1999) Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg 134:1131–1136PubMedCrossRef
7.
Zurück zum Zitat Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G, Bernades P, Belghiti J, Ruszniewski P, Flejou JF (2000) Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 24:1372–1377PubMedCrossRef Terris B, Ponsot P, Paye F, Hammel P, Sauvanet A, Molas G, Bernades P, Belghiti J, Ruszniewski P, Flejou JF (2000) Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 24:1372–1377PubMedCrossRef
8.
Zurück zum Zitat Doi R, Fujimoto K, Wada M, Imamura M (2002) Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 132:80–85PubMedCrossRef Doi R, Fujimoto K, Wada M, Imamura M (2002) Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery 132:80–85PubMedCrossRef
9.
Zurück zum Zitat Matsumoto T, Aramaki M, Yada K, Hirano S, Himeno Y, Shibata K, Kawano K, Kitano S (2003) Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 36:261–265PubMedCrossRef Matsumoto T, Aramaki M, Yada K, Hirano S, Himeno Y, Shibata K, Kawano K, Kitano S (2003) Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 36:261–265PubMedCrossRef
10.
Zurück zum Zitat Kitagawa Y, Unger TA, Taylor S, Kozarek RA, Traverso LW (2003) Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 7:12–19PubMedCrossRef Kitagawa Y, Unger TA, Taylor S, Kozarek RA, Traverso LW (2003) Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 7:12–19PubMedCrossRef
11.
Zurück zum Zitat Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–799PubMedCrossRef Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–799PubMedCrossRef
12.
Zurück zum Zitat Salvia R, Fernández-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL (2004) Main duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678–687PubMedCrossRef Salvia R, Fernández-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL (2004) Main duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678–687PubMedCrossRef
13.
Zurück zum Zitat Lee SY, Lee KT, Lee JK, Jeon YH, Choi D, Lim JH, Heo JS, Choi SH, Jang KT, Paik SW, Rhee JC (2005) Long-term follow up results of intraductal papillary mucinous tumors of pancreas. J Gastroenterol Hepatol 20:1379–1884PubMedCrossRef Lee SY, Lee KT, Lee JK, Jeon YH, Choi D, Lim JH, Heo JS, Choi SH, Jang KT, Paik SW, Rhee JC (2005) Long-term follow up results of intraductal papillary mucinous tumors of pancreas. J Gastroenterol Hepatol 20:1379–1884PubMedCrossRef
14.
Zurück zum Zitat Z’graggen K, Rivera JA, Corris PA et al (1997) Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 226:491–498PubMedCrossRef Z’graggen K, Rivera JA, Corris PA et al (1997) Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 226:491–498PubMedCrossRef
15.
Zurück zum Zitat Islam HK, Fujioka Y, Tomidokoro T et al (2001) Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas. Hepatogastroenterology 38:879–883 Islam HK, Fujioka Y, Tomidokoro T et al (2001) Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas. Hepatogastroenterology 38:879–883
16.
Zurück zum Zitat Sasaki S, Yamamoto H, Kaneto H et al (2003) Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep 10:21–25PubMed Sasaki S, Yamamoto H, Kaneto H et al (2003) Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas. Oncol Rep 10:21–25PubMed
17.
Zurück zum Zitat Hruban RH, Takaori K, Klimstra DS, Adsey NV et al (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm. Am J Surg Pathol 28:977–987PubMedCrossRef Hruban RH, Takaori K, Klimstra DS, Adsey NV et al (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm. Am J Surg Pathol 28:977–987PubMedCrossRef
18.
Zurück zum Zitat Falconi M, Salvia R, Bassi C, Zamboni G, Talamini G, Pederzoli P (2001) Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 88:376–381PubMedCrossRef Falconi M, Salvia R, Bassi C, Zamboni G, Talamini G, Pederzoli P (2001) Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 88:376–381PubMedCrossRef
19.
Zurück zum Zitat Ban S, Naitoh Y, Mino-Kenudson M, Sakurai t, Kuroda M, Koyama I, Lauwers GY, Shimizu M (2006) Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 30:1561–1569PubMedCrossRef Ban S, Naitoh Y, Mino-Kenudson M, Sakurai t, Kuroda M, Koyama I, Lauwers GY, Shimizu M (2006) Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 30:1561–1569PubMedCrossRef
20.
Zurück zum Zitat Wada K (2002) p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg 9:76–85PubMedCrossRef Wada K (2002) p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg 9:76–85PubMedCrossRef
21.
Zurück zum Zitat Biankin AV, Biankin SA, Kench JG et al (2002) Aberrant p16(INK4A) and DPC4Smad4 expression in intraductal papillary mucinous tumors of the pancreas is associated with invasive ductal adenocarcinoma. Gut 50:861–868PubMedCrossRef Biankin AV, Biankin SA, Kench JG et al (2002) Aberrant p16(INK4A) and DPC4Smad4 expression in intraductal papillary mucinous tumors of the pancreas is associated with invasive ductal adenocarcinoma. Gut 50:861–868PubMedCrossRef
22.
Zurück zum Zitat Suzuki Z, Atomi Z, Sugizama M, Isaji S, Inui K, Kimura W, Sunamura M, Furukawa T, Zanagisawa A, Arizama J, Takada T, Watanabe H, Suda K (2004) Cystic neoplasm of the pancreas. A Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 28:241–246PubMedCrossRef Suzuki Z, Atomi Z, Sugizama M, Isaji S, Inui K, Kimura W, Sunamura M, Furukawa T, Zanagisawa A, Arizama J, Takada T, Watanabe H, Suda K (2004) Cystic neoplasm of the pancreas. A Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 28:241–246PubMedCrossRef
23.
Zurück zum Zitat Osanai M, Tanno S, Nakano Y et al (2003) Extrapancreatic neoplasms in patients with intraductal papillary mucinous tumors of the pancreas. J Jpn Pancreas Soc 18:565–569 Osanai M, Tanno S, Nakano Y et al (2003) Extrapancreatic neoplasms in patients with intraductal papillary mucinous tumors of the pancreas. J Jpn Pancreas Soc 18:565–569
24.
Zurück zum Zitat Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS (2002) Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer 1:62–77CrossRef Adsay NV, Conlon KC, Zee SY, Brennan MF, Klimstra DS (2002) Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer 1:62–77CrossRef
25.
Zurück zum Zitat Yamaguchi K, Yokohata K, Noshiro H, Chijiiwa K, Tanaka M (2000) Mucinous cystic neoplasm of the pancreas or intraductal papillary-mucinous tumour of the pancreas. Eur J Surg 166:141–148PubMedCrossRef Yamaguchi K, Yokohata K, Noshiro H, Chijiiwa K, Tanaka M (2000) Mucinous cystic neoplasm of the pancreas or intraductal papillary-mucinous tumour of the pancreas. Eur J Surg 166:141–148PubMedCrossRef
26.
Zurück zum Zitat Sugiyama M, Atomi Y (1999) Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 94:470–447PubMedCrossRef Sugiyama M, Atomi Y (1999) Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 94:470–447PubMedCrossRef
27.
Zurück zum Zitat Salvia R, Fernándey-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 239:678–68PubMedCrossRef Salvia R, Fernándey-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 239:678–68PubMedCrossRef
28.
Zurück zum Zitat D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC (2004) Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 239:400–408PubMedCrossRef D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC (2004) Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 239:400–408PubMedCrossRef
29.
Zurück zum Zitat Wiesenauer CA, Schmidt CM, Cummings OW, Yiannoutsos CT, Howard TJ, Wiebke EA, Goulet RJ Jr, McHenry L, Sherman S, Lehman GA, Cramer H, Madura JA (2003) Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg 138:610–617PubMedCrossRef Wiesenauer CA, Schmidt CM, Cummings OW, Yiannoutsos CT, Howard TJ, Wiebke EA, Goulet RJ Jr, McHenry L, Sherman S, Lehman GA, Cramer H, Madura JA (2003) Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg 138:610–617PubMedCrossRef
30.
Zurück zum Zitat Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD (2001) Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 234:313–323PubMedCrossRef Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD (2001) Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 234:313–323PubMedCrossRef
31.
Zurück zum Zitat Bernard P, Scoazel JY, Joubert M (2002) Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases. Arch Surg 137:1274–1278PubMedCrossRef Bernard P, Scoazel JY, Joubert M (2002) Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases. Arch Surg 137:1274–1278PubMedCrossRef
32.
Zurück zum Zitat Murakami Y, Yokolyama T, Hiayama E et al (2002) Successful preoperative diagnosis of malignant intraductal papillary tumor of the pancreas by detecting telomerase activity. Int J Gastrointest Cancer 31:117–121PubMedCrossRef Murakami Y, Yokolyama T, Hiayama E et al (2002) Successful preoperative diagnosis of malignant intraductal papillary tumor of the pancreas by detecting telomerase activity. Int J Gastrointest Cancer 31:117–121PubMedCrossRef
33.
Zurück zum Zitat Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, Howard TJ, Zyromski NJ, Nakeeb A, DeWitt JM, Akisik FM, Sherman S, Pitt HA, Lillemoe KD (2007) Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 246:644–654PubMedCrossRef Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, Howard TJ, Zyromski NJ, Nakeeb A, DeWitt JM, Akisik FM, Sherman S, Pitt HA, Lillemoe KD (2007) Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 246:644–654PubMedCrossRef
34.
Zurück zum Zitat Kimura W (2003) IHPBA in Tokyo, 2002: surgical treatment of IPMT vs MCT: a Japanese experience. J Hepatobiliary Pancreat Surg 10:156–162PubMedCrossRef Kimura W (2003) IHPBA in Tokyo, 2002: surgical treatment of IPMT vs MCT: a Japanese experience. J Hepatobiliary Pancreat Surg 10:156–162PubMedCrossRef
35.
Zurück zum Zitat Adsey NV, Merati K, Aneda A et al (2002) The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas. Mod Path 15:1087–1095CrossRef Adsey NV, Merati K, Aneda A et al (2002) The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas. Mod Path 15:1087–1095CrossRef
36.
Zurück zum Zitat Brat DJ, Lillemoe KD, Yeo CD et al (1998) Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 22:163–169PubMedCrossRef Brat DJ, Lillemoe KD, Yeo CD et al (1998) Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. Am J Surg Pathol 22:163–169PubMedCrossRef
37.
Zurück zum Zitat Andea AA, Cheng J, Lauwers GY, Klimstra DS (2002) Assay in pancreatic intraepithelial neoplasia (PanIN) in pancreata involved by mucinous cystic neoplasm. Med Pathol 15:282A Andea AA, Cheng J, Lauwers GY, Klimstra DS (2002) Assay in pancreatic intraepithelial neoplasia (PanIN) in pancreata involved by mucinous cystic neoplasm. Med Pathol 15:282A
38.
Zurück zum Zitat Takada T, Yasuda K, Uchiyama K, Hasegawa H (1993) Duodenum-preserving pancreatoduodenostomy. A new technique for complete excision of the head of the pancreas with preservation of biliary and alimentary integrity. Hepatogastroenterology 40:356–359PubMed Takada T, Yasuda K, Uchiyama K, Hasegawa H (1993) Duodenum-preserving pancreatoduodenostomy. A new technique for complete excision of the head of the pancreas with preservation of biliary and alimentary integrity. Hepatogastroenterology 40:356–359PubMed
39.
Zurück zum Zitat Imaizumi T, Hanyu F, Suzuki M, Nakasako T, Harada N, Hatori T (1995) Clinical experience with duodenum-preserving total resection of the head of the pancreas with pancreaticocholedochoduodenostomy. J Hepatobiliary Pancreat Surg 2:38–44CrossRef Imaizumi T, Hanyu F, Suzuki M, Nakasako T, Harada N, Hatori T (1995) Clinical experience with duodenum-preserving total resection of the head of the pancreas with pancreaticocholedochoduodenostomy. J Hepatobiliary Pancreat Surg 2:38–44CrossRef
40.
Zurück zum Zitat Schwarz A, Beger HG (1996) Modifikation der duodenumerhaltenden pankreaskopfresektion mit segment-resektion der duodenum-erfahrung mit 4 patienten (vortrag). Jahrestagung der Mittelrheinischen Chirurgen, Ulm (September) Schwarz A, Beger HG (1996) Modifikation der duodenumerhaltenden pankreaskopfresektion mit segment-resektion der duodenum-erfahrung mit 4 patienten (vortrag). Jahrestagung der Mittelrheinischen Chirurgen, Ulm (September)
41.
Zurück zum Zitat Nagakawa T, Ohta T, Kayahara M, Ueno K (1997) Total resection of the head of the pancreas preserving the duodenum, bile duct and papilla with end-to-end anastomosis of the pancreatic duct. Am J Surg 173:210–212PubMedCrossRef Nagakawa T, Ohta T, Kayahara M, Ueno K (1997) Total resection of the head of the pancreas preserving the duodenum, bile duct and papilla with end-to-end anastomosis of the pancreatic duct. Am J Surg 173:210–212PubMedCrossRef
42.
Zurück zum Zitat Nakao A (1998) Pancreatic head resection with segmental duodenectomy and preservation of the gastroduodenal artery. Hepatogastroenterology 45:533–535PubMed Nakao A (1998) Pancreatic head resection with segmental duodenectomy and preservation of the gastroduodenal artery. Hepatogastroenterology 45:533–535PubMed
43.
Zurück zum Zitat Pedrazzoli S, Sperti C, Pasquali C (2001) Pancreatic head resection for noninflammatory benign lesions of the head of the pancreas. Pancreas 23:309–315PubMedCrossRef Pedrazzoli S, Sperti C, Pasquali C (2001) Pancreatic head resection for noninflammatory benign lesions of the head of the pancreas. Pancreas 23:309–315PubMedCrossRef
44.
Zurück zum Zitat Isaji S, Kawarada Y (2001) Pancreatic head resection with second portion duodenectomy for benign lesions, low-grade malignancies, and early stage carcinomas involving the pancreatic head resection. Am J Surg 181:172–176PubMedCrossRef Isaji S, Kawarada Y (2001) Pancreatic head resection with second portion duodenectomy for benign lesions, low-grade malignancies, and early stage carcinomas involving the pancreatic head resection. Am J Surg 181:172–176PubMedCrossRef
45.
Zurück zum Zitat Ahn YJ, Kim SW, Park YC, Jang JY, Yoon YS, Park YH (2003) Duodenal-preserving resection of the head of the pancreas and pancreatic head resection with second-portion duodenectomy for benign lesions, low-grade malignancies and early carcinoma involving the periampullary region. Arch Surg 138:162–168PubMedCrossRef Ahn YJ, Kim SW, Park YC, Jang JY, Yoon YS, Park YH (2003) Duodenal-preserving resection of the head of the pancreas and pancreatic head resection with second-portion duodenectomy for benign lesions, low-grade malignancies and early carcinoma involving the periampullary region. Arch Surg 138:162–168PubMedCrossRef
46.
Zurück zum Zitat Murakami Y, Uemura K, Yokoyama Y, Sasaki M, Morifuji M, Hayashidani Y, Sudo T, Sueda T (2004) Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg 8:713–718PubMedCrossRef Murakami Y, Uemura K, Yokoyama Y, Sasaki M, Morifuji M, Hayashidani Y, Sudo T, Sueda T (2004) Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg 8:713–718PubMedCrossRef
47.
Zurück zum Zitat Hirano S, Kondro S, Amtso Y et al (2004) Outcome of duodenum-preserving resection of the head of the pancreas for intraductal papillary mucinous neoplasms. Dig Dis 21:242–245CrossRef Hirano S, Kondro S, Amtso Y et al (2004) Outcome of duodenum-preserving resection of the head of the pancreas for intraductal papillary mucinous neoplasms. Dig Dis 21:242–245CrossRef
48.
Zurück zum Zitat Nakao A, Fernandez Cruz L (2007) Pancreatic head resection with segmental duodenectomy: safety and long-term results. Ann Surg 246:923–928 Nakao A, Fernandez Cruz L (2007) Pancreatic head resection with segmental duodenectomy: safety and long-term results. Ann Surg 246:923–928
49.
Zurück zum Zitat Imaizumi T, Hatori T, Harada N et al (2007) Intraductal papillary neoplasm of the pancreas; resection and cancer prevention. Am J Surg 194(S1):S95–S99 Imaizumi T, Hatori T, Harada N et al (2007) Intraductal papillary neoplasm of the pancreas; resection and cancer prevention. Am J Surg 194(S1):S95–S99
50.
Zurück zum Zitat Thayer SP, Fernández-del Castillo C, Balcom JH, Warshaw AL (2002) Complete dorsal pancreatectomy with preservation of the ventral pancreas: a new surgical technique. Surgery 131:577–580PubMedCrossRef Thayer SP, Fernández-del Castillo C, Balcom JH, Warshaw AL (2002) Complete dorsal pancreatectomy with preservation of the ventral pancreas: a new surgical technique. Surgery 131:577–580PubMedCrossRef
51.
Zurück zum Zitat Howard TJ, Jones JW, Sharman S et al (2001) Impact of pancreatic head resection on direct medical costs in patients with chronic pancreatitis. Ann Surg 234:661–667PubMedCrossRef Howard TJ, Jones JW, Sharman S et al (2001) Impact of pancreatic head resection on direct medical costs in patients with chronic pancreatitis. Ann Surg 234:661–667PubMedCrossRef
52.
Zurück zum Zitat Reddy RP, Smyrk TC, Zapiach M, Levy MJ, Pearson RK, Clain JE, Farnell MB, Sarr MG, Chari ST (2004) Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2:1026–1031PubMedCrossRef Reddy RP, Smyrk TC, Zapiach M, Levy MJ, Pearson RK, Clain JE, Farnell MB, Sarr MG, Chari ST (2004) Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol 2:1026–1031PubMedCrossRef
53.
Zurück zum Zitat Watanabe G, Matsuda M, Kajiyama Y, Udagawa H et al (1991) Clinical aspects for the resection of the uncinate process of the pancreas. Biliary Tract & Pancreas 12:1369–1372 Watanabe G, Matsuda M, Kajiyama Y, Udagawa H et al (1991) Clinical aspects for the resection of the uncinate process of the pancreas. Biliary Tract & Pancreas 12:1369–1372
54.
Zurück zum Zitat Nakagohri T, Kenmochi T, Kainuma O, Tokoro Y, Kobayashi S, Asano T (2000) Inferior head resection of the pancreas for intraductal papillary mucinous tumors. Am J Surg 179:482–484PubMedCrossRef Nakagohri T, Kenmochi T, Kainuma O, Tokoro Y, Kobayashi S, Asano T (2000) Inferior head resection of the pancreas for intraductal papillary mucinous tumors. Am J Surg 179:482–484PubMedCrossRef
55.
Zurück zum Zitat Büchler M, Friess H, Müller MW, Wheatley AM, Beger HG (1995) Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancratitis. Am J Surg 169:65–70PubMedCrossRef Büchler M, Friess H, Müller MW, Wheatley AM, Beger HG (1995) Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancratitis. Am J Surg 169:65–70PubMedCrossRef
56.
Zurück zum Zitat Klempa I, Spatny M, Menzel J et al (1995) Pankreasfunktion und lebensqualität nach pankreaskopfresektion bei der chronischen pankreatitis. Chirurg 66:350–359PubMed Klempa I, Spatny M, Menzel J et al (1995) Pankreasfunktion und lebensqualität nach pankreaskopfresektion bei der chronischen pankreatitis. Chirurg 66:350–359PubMed
57.
Zurück zum Zitat Witzigmann H, Max D, Uhlmann D, Geissler F, Schwarz R, Ludwig S et al (2003) Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis. Surgery 134:53–62PubMedCrossRef Witzigmann H, Max D, Uhlmann D, Geissler F, Schwarz R, Ludwig S et al (2003) Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis. Surgery 134:53–62PubMedCrossRef
Metadaten
Titel
Duodenum-preserving total pancreatic head resection for cystic neoplasm—a limited but cancer-preventive procedure
verfasst von
Hans G. Beger
Bettina M. Rau
Frank Gansauge
Michael Schwarz
Marko Siech
Bertram Poch
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 4/2008
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-008-0323-5

Weitere Artikel der Ausgabe 4/2008

Langenbeck's Archives of Surgery 4/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.